IP Verse

Treatment Of Obesity, The Metabolic Syndrome, Type 2 Diabetes, Cardiovascular Diseases, Dementia, Alzheimer'S Disease And Inflammatory Bowel Disease By Using At Least One Bacterial Strain From Prevotella

Patent No. EP3016527 (titled "Treatment Of Obesity, The Metabolic Syndrome, Type 2 Diabetes, Cardiovascular Diseases, Dementia, Alzheimer'S Disease And Inflammatory Bowel Disease By Using At Least One Bacterial Strain From Prevotella") was filed by Proprev on May 27, 2014. The application was issued on Jul 25, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DUPONT NUTRITION BIOSCIENCES APSApr 24, 2019N&H EMEA

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3016527

PROPREV
Application Number
EP14808269A
Filing Date
May 27, 2014
Status
Opposition Rejected
Jun 16, 2023
Publication Date
Jul 25, 2018
External Links
Slate, Register , Google Patents